Search Tag: revenue growth

Executive Health Management

2024 21 May

  Launch of 20 new medicines expected by 2030 Significant growth from existing oncology, biopharmaceuticals and rare disease portfolios Investing in disruptive innovation that will shape the future of medicine and drive long-term growth Decoupling carbon emissions from revenue growth   AstraZeneca revealed its bold ambition to deliver...Read more

Sustainability

2024 21 May

  Launch of 20 new medicines expected by 2030 Significant growth from existing oncology, biopharmaceuticals and rare disease portfolios Investing in disruptive innovation that will shape the future of medicine and drive long-term growth Decoupling carbon emissions from revenue growth   AstraZeneca revealed its bold ambition to deliver...Read more

Executive Health Management

2024 07 May

  Siemens Healthineers AG announces its results for the second quarter of fiscal year 2024 ended March 31, 2024.   Q2 Fiscal Year 2024  Good equipment book-to-bill ratio of 1.08  Comparable revenue growth of 3.0% against a very good prior-year quarter (excluding rapid COVID-19 antigen tests, growth of 11.7%)  Imaging comparable revenue...Read more